Type
Ciomal Vierteijahres Mitteilungen [Internet]. Ciomal; 2016. Available from: http://ciomal.ch/publications/bulletins/
Type
Ciomal Bolletino trimestriale [Internet]. Ciomal; 2016. Available from: http://ciomal.ch/publications/bulletins/
Type
Kaur G, Kaur J, Pandey B, Kumar A, Garewal N, Grover A. Drug targeted virtual screening and molecular dynamics of LipU protein of Mycobacterium tuberculosis and Mycobacterium leprae. Journal of biomolecular structure & dynamics. 2018;:1-38.
Type
Suneetha S, Rao N. Current situation of leprosy in India and its future implications. Indian dermatology online journal [Internet]. 2018;9(2):83-89. Available from: http://www.idoj.in/temp/IndianDermatolOnlineJ9283-2552301_070523.pdf
Type
Perera J, Gunasekera C, Satgurunathan K, Kahawita I. 100 cases of leprosy . Colombo: Sri Lanka Medical Association ; 2015.
Type
Tarique M, Naqvi RA, Ali R, Khanna N, Rao. CD4(+) TCRγδ(+) FoxP3(+) cells: An unidentified population of immunosuppressive cells towards disease progression leprosy patients. Experimental dermatology [Internet]. 2017;. Available from: http://onlinelibrary.wiley.com/doi/10.1111/exd.13302/epdf
Type
Nsagha D, Bissek A-C, Nsagha S, Njunda A, Assob J, Tabah E, et al. Social stigma as an epidemiological determinant for leprosy elimination in Cameroon. Journal of public health in Africa [Internet]. 2011;2(1):e10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345469/pdf/jphia-2011-1-e10.pdf
Type
Cardona-Castro N. Leprosy in Colombia: post elimination stage?. Leprosy review [Internet]. 2013;84(3):238-47. Available from: https://leprosyreview.org/article/84/3/23-8247
Type
Ebenso J, Ebenso B. Monitoring impairment in leprosy: choosing the appropriate tool. Leprosy review [Internet]. 2007;78(3):270-80. Available from: https://leprosyreview.org/article/78/3/27-0280
Type
Sharma A, Equbal, Pandey, Sheikh J, Ehtesham N, Hasnain S, et al. Immunodominant protein MIP_05962 from Mycobacterium indicus pranii displays chaperone activity. The FEBS journal. 2017;.